Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock ...

Shell ( NYSE: SHEL) -2.5% in Wednesday's trading following its disappointing Q4 update, but UBS nevertheless upgrades shares ...

Fintel reports that on January 8, 2025, UBS upgraded their outlook for Novo Nordisk A (NYSE:NVO) from Sell to Buy. Analyst ...

Fintel reports that on January 7, 2025, UBS upgraded their outlook for Bank of America Corporation - Preferred Stock ...

UBS analyst Joshua Stone upgraded Shell (SHEL) to Buy from Neutral with a price target of 3,000 GBp, up from 2,800 GBp. Shell now has the ...

The Swiss bank expects the city’s benchmark index to rise above 20,000 by year-end, implying a gain of 3.7 per cent from ...

UBS raised the firm’s price target on United Therapeutics (UTHR) to $475 from $415 and keeps a Buy rating on the shares as part of a broader ...

ASX dips as retail data cools rate cut hopes, Star tanks on cash burn, and Bitcoin stumbles as China faces deflation.

Brokerages remained divided on the stock after Tata Motors subsidiary JLR released its sales number for the third quarter of ...

Investing.com - Novo Nordisk (CSE: NOVOb ) remains the "most exciting growth story" in the European pharmaceutical sector and ...

Embattled fast-fashion jewellery chain Lovisa has been downgraded due to concerns over its future earnings because of a ...

We recently compiled a list of the 9 Stocks Poised for Gains as AI Reaches New Heights in 2025. In this article, we are going ...